Latest / Decera Clinical Education Oncology Podcast
Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease
In this podcast episode, Conor Ernst Steuer, MD, a medical oncologist; Frank Schneider, MD, a pathologist; and Elise Hitron, MSN, FNP-C, a phase I clinical trials nurse practitioner, engage in a multidisciplinary discussion of the latest management strategies for EGFR-mutated NSCLC. Topics include:
Testing for targetable biomarkers
Talking with patients about biomarker testing
Frontline therapy for EGFR-positive NSCLC
Resistance to front-line osimertinib
Treatment of EGFR TKI–resistant disease, including the emerging antibody–drug conjugate patritumab deruxtecan
HER3 protein testing
Pathology…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.